A novel method to measure functional status of ErbB2 in breast cancer

被引：0
|
作者：
Kong, Anthony
Leboucher, Pierre
Leek, Russell
Winter, Stuart
Harris, Adrian
Parker, Peter
Larijani, Banafshe
机构：
[1] London Res Inst, Canc Res UK, London, England
[2] Coll France, Lab Physiol Percept & Act, Paris, France
[3] Univ Oxford, Inst Mol Med, Oxford, England
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1952
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression
    Kim, Yeong Hwa
    Kim, Jang-Hee
    Choi, Yong Won
    Lim, Seo Kyung
    Yim, Hyunee
    Kang, Seok Yun
    Chung, Yong Sik
    Lee, Ga-Young
    Park, Tae Jun
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (02) : 360 - 365
  • [42] The ErbB2 pathway in breast cancer: best approaches for maximum efficacy
    Spector, N
    Xia, W
    Harris, J
    Mangum, S
    Bacus, S
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S5 - S5
  • [43] Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy
    Dmitrii Bychkov
    Nina Linder
    Aleksei Tiulpin
    Hakan Kücükel
    Mikael Lundin
    Stig Nordling
    Harri Sihto
    Jorma Isola
    Tiina Lehtimäki
    Pirkko-Liisa Kellokumpu-Lehtinen
    Karl von Smitten
    Heikki Joensuu
    Johan Lundin
    Scientific Reports, 11
  • [44] ERBB2 oncogene in human breast cancer and its clinical significance
    Révillion, F
    Bonneterre, J
    Peyrat, JP
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (06) : 791 - 808
  • [45] Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue
    Fernandez, Aileen, I
    Liu, Matthew
    Bellizzi, Andrew
    Brock, Jane
    Fadare, Oluwole
    Hanley, Krisztina
    Harigopal, Malini
    Jorns, Julie M.
    Kuba, M. Gabriela
    Ly, Amy
    Podoll, Mirna
    Rabe, Kimmie
    Sanders, Mary Ann
    Singh, Kamaljeet
    Snir, Olivia L.
    Soong, T. Rinda
    Wei, Shi
    Wen, Hannah
    Wong, Serena
    Yoon, Esther
    Pusztai, Lajos
    Reisenbichler, Emily
    Rimm, David L.
    JAMA ONCOLOGY, 2022, 8 (04) : 607 - 610
  • [46] DNA structural features on borders of ERBB2 amplicons in breast cancer
    N. Yu. Matsenko
    S. P. Kovalenko
    Molecular Biology, 2013, 47 : 712 - 720
  • [47] ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines
    C Ginestier
    J Adélaïde
    A Gonçalvès
    L Repellini
    F Sircoulomb
    A Letessier
    P Finetti
    J Geneix
    E Charafe-Jauffret
    F Bertucci
    J Jacquemier
    P Viens
    D Birnbaum
    Oncogene, 2007, 26 : 7163 - 7169
  • [48] Genetic immunization against neu /erbB2 transgenic breast cancer
    Augusto Amici
    Franco Maria Venanzi
    Antonio Concetti
    Cancer Immunology, Immunotherapy, 1998, 47 : 183 - 190
  • [49] Complex genomic regions associated with ERBB2 amplification in breast cancer
    Tanaka, Hisashi
    Marotta, Michael
    Tubbs, Raymond R.
    CANCER RESEARCH, 2012, 72
  • [50] Development of a multiplex dPCR assay for ERBB2 amplification in breast cancer
    Meng, P.
    Dalal, H.
    Chen, Y.
    Ehinger, A.
    Alcaide, M.
    Saal, L.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S80 - S80
12345